Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03041883
NA

Corneal Collagen Crosslinking to Increase the Resistance of the Support Graft of the KPro Type I Against Corneal Melting

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

View on ClinicalTrials.gov

Summary

The purpose of this study is to demonstrate the safety and efficacy of the corneal collagen crosslinking with riboflavin and ultraviolet A in aim to increase the resistance of the graft used as a support for the Boston keratoprosthesis (KPro) type I against corneal melting (keratolysis or sterile necrosis).

Official title: Corneal Collagen Crosslinking to Increase the Resistance of the Graft Used as a Support for the Boston Keratoprosthesis Type I Against Corneal Melting

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2017-01-04

Completion Date

2025-01

Last Updated

2024-04-19

Healthy Volunteers

No

Interventions

PROCEDURE

Crosslinking with riboflavin of the corneal graft-support

Corneal graft support for the KPro will be crosslinked and used with the standard surgical technique

PROCEDURE

De-epithelisation of the corneal graft support with instillation of riboflavin

Corneal graft-support will be de-epithelialized and soaked with riboflavin and then used with the standard surgical technique

Locations (1)

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada